*Corresponding author:Dr. Carmen Gruber Traub, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Nobelstrasse 12, 70569 Stuttgart, Germany
Received: May 04, 2018; Published: May 10, 2018
To view the Full Article Peer-reviewed Article PDF
Within the EU funded project »N2B-patch« eleven partners from eight countries aim to develop an innovative technology for the nose-to-brain delivery of an active pharmaceutical ingredient via the olfactory region for the regenerative treatment of multiple sclerosis using novel multi-functional biomaterials combined with a medical device. The four year EU-funded research involves an innovative method of bypassing the blood-brain barrier by delivering a potential multiple sclerosis drug with a special medical device via the nose directly to the brain.
Keywords: nose-to-brain, multiple sclerosis, multi-functional biomaterial, drug delivery, API-loaded particles
We know the financial complexity of Individual read more...
The annual scholar awards from Lupine Publishers honor a selected number read more...